Precision Medicine for Your Practice

CME and CNE modules on the clinical applications of genetic testing

How can genetics be used in clinic with my patients? Can genetic information really improve outcomes? Genetic testing is constantly changing. How can I keep up?

Precision Medicine for Your Practice is an educational program being developed by Scripps Research Translational Institute (Scripps), the American Medical Association (AMA), and The Jackson Laboratory (JAX) to help clinicians answer these questions. In each module, you will have the opportunity to:

Practice applying genetic information to realistic cases

Assess the utility of genetic information

Learn about benefits and limitations of new genetic tests

This on-demand, interactive program will consist of a series of 12 modules that are 15-30 minutes, case-based and aim to build clinical skills and impact patient care. Topics include prenatal testing, targeted therapy in oncology, genomic sequencing, cardiogenomics, neurogenomics, pharmacogenomics and ethics in precision medicine. Modules will be released individually, and each will be designated for continuing medical education (CME) and continuing nursing education (CE) credit.

Latest Module

Exome Testing for Diagnosis

Identify patients who may benefit from exome testing, communicate with patients and families about testing, recognize clinically significant exome test results, and collaborate with genetic experts.

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Medical Association designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing nursing education activity was approved by the Northeast Multi-State Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.